2DPA-1 Market Size, Share, and Growth Analysis, By Application (Pharmaceuticals, Agrochemicals), By End Use (Healthcare, Textile & Dye), By Region - Industry Forecast 2025-2032
2DPA-1 시장 규모는 2023년 6,654억 4,000만 달러로 평가되었고, 예측 기간(2025-2032년) 동안 3.8%의 연평균 복합 성장률(CAGR)로 2024년 6,907억 3,000만 달러에서 2032년에는 9,308억 6,000만 달러로 성장할 것으로 예상됩니다.
2DPA-1 세계 시장은 제약, 농약, 염료 제조, 퍼스널케어 등 다양한 분야에서 이 화합물의 다재다능한 용도에 힘입어 지속적으로 성장하고 있습니다. 독특한 특성으로 알려진 2DPA-1(2-디페닐아세틸-1,3-인단디온)은 많은 제제에서 중요한 화학 중간체 역할을 하며, 스킨케어 제품에서 노화 방지 및 항산화 작용과 같은 유익한 특성으로 찬사를 받고 있습니다. 다양한 산업 분야에서 이러한 수요 증가는 혁신적인 솔루션을 활용하고자 하는 시장 참여자들에게 큰 성장 잠재력을 강조합니다. 또한, 미국 2DPA-1 시장은 향후 1년간 지속적인 CAGR을 유지할 것으로 예상되며, 이는 이 역동적인 분야에 대한 투자 및 시장 개발의 기회임을 강조하고 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 사례 연구
- 규제 상황
- 특허 분석
2DPA-1시장 규모 : 용도별&CAGR(2025-2032)
2DPA-1시장 규모 : 최종 용도별&CAGR(2025-2032)
2DPA-1시장 규모 : 지역별&CAGR(2025-2032)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 전년대비 매출 비교(2022-2024년)
주요 기업 개요
- Siemens AG(Germany)
- GE Healthcare(United States)
- Philips Healthcare(Netherlands)
- Canon Medical Systems Corporation(Japan)
- Hitachi, Ltd.(Japan)
- Toshiba Medical Systems Corporation(Japan)
- Koninklijke Philips N.V.(Netherlands)
- Fujifilm Holdings Corporation(Japan)
- Carestream Health, Inc.(United States)
- Esaote SpA(Italy)
- Samsung Medison Co., Ltd.(South Korea)
- Hologic, Inc.(United States)
- Mindray Medical International Limited(China)
- Agfa-Gevaert NV(Belgium)
- Shimadzu Corporation(Japan)
- CurveBeam LLC(United States)
- Planmed Oy(Finland)
- Medtronic plc(Ireland)
- Varian Medical Systems, Inc.(United States)
- Epiroc AB(Sweden)
결론과 제안
LSH
2DPA-1 Market size was valued at USD 665.44 billion in 2023 and is poised to grow from USD 690.73 billion in 2024 to USD 930.86 billion by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).
The global 2DPA-1 market is on the rise, driven by the compound's versatile applications in various sectors, including pharmaceuticals, agrochemicals, dye production, and personal care. Known for its unique properties, 2DPA-1 (2-diphenylacetyl-1,3-indandione) serves as a critical chemical intermediate in many formulations and is praised for its beneficial attributes like anti-aging and antioxidant effects in skincare products. This escalating demand across diverse industries underscores significant growth potential for market players looking to leverage innovative solutions. Furthermore, the US 2DPA-1 market is anticipated to maintain a sustainable CAGR in the coming forecast year, highlighting an opportune moment for investment and development in this dynamic sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the 2DPA-1 market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2DPA-1 Market Segments Analysis
Global 2DPA-1 Market is segmented by Application, End Use and region. Based on Application, the market is segmented into Pharmaceuticals, Agrochemicals, Cosmetics and Others. Based on End Use, the market is segmented into Healthcare, Textile & Dye and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the 2DPA-1 Market
The pharmaceutical sector is perpetually on the lookout for new and groundbreaking drug candidates to tackle diverse health issues. The distinctive therapeutic attributes of 2DPA-1-encompassing anti-inflammatory, anti-cancer, and antiviral properties-are propelling its utilization in drug discovery and development. This increasing interest and reliance on 2DPA-1 are contributing to a notable cumulative annual growth rate (CAGR) for the global market of 2DPA-1 over the projected timeframe. As the demand for effective treatments escalates, 2DPA-1 stands out as a promising candidate, further stimulating its integration into various therapeutic applications and solidifying its position within the pharmaceutical landscape.
Restraints in the 2DPA-1 Market
The emergence of new entrants in both regional and global markets may enhance competitiveness, potentially jeopardizing the positions of established players. As these newcomers introduce innovative products and diversify their offerings, existing businesses must adapt and refine their strategies to maintain market share. A robust and improved product portfolio from competitors could heighten the stakes, prompting a more aggressive approach to marketing and innovation among current players. This dynamic landscape necessitates that established firms continually assess their value propositions and respond effectively to the challenges posed by fresh market participants, ensuring their sustainability and growth in an increasingly competitive environment.
Market Trends of the 2DPA-1 Market
The 2DPA-1 market is currently facing a trend characterized by its intricate and costly production processes, which impede its broader adoption across industries. As manufacturers grapple with high production costs, the economic viability of 2DPA-1 becomes a significant concern, potentially limiting its accessibility and affordability. This financial barrier could hinder market expansion, resulting in a relatively modest compound annual growth rate (CAGR) throughout the forecast period. Despite its potential applications, the complexity of 2DPA-1 manufacturing may deter widespread usage, making it essential for industry players to innovate and streamline production techniques to boost market growth.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Studies
- Regulatory Landscape
- Patent Analysis
Global 2DPA-1 Market Size by Application & CAGR (2025-2032)
- Market Overview
- Pharmaceuticals
- Agrochemicals
- Cosmetics
- Others
Global 2DPA-1 Market Size by End Use & CAGR (2025-2032)
- Market Overview
- Healthcare
- Textile & Dye
- Others
Global 2DPA-1 Market Size & CAGR (2025-2032)
- North America (Application, End Use)
- Europe (Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Application, End Use)
- Brazil
- Rest of Latin America
- Middle East & Africa (Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Siemens AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Toshiba Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Carestream Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Esaote SpA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Samsung Medison Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agfa-Gevaert NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CurveBeam LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Varian Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Epiroc AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
